Bomb Report – Lifestyle
Author:
SERB Pharmaceuticals
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
May 19, 2026
SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US
May 7, 2026